Are Sampre Nutrition latest results good or bad?

Jul 18 2025 07:13 PM IST
share
Share Via
Sampre Nutrition's latest results show strong net sales growth at Rs 7.77 crore, the highest in five quarters, but significant losses in profitability with a PBT of Rs -7.52 crore and a PAT of Rs -7.35 crore, indicating a challenging financial outlook.
Sampre Nutritions has reported its financial results for the quarter ending March 2025, showcasing a complex performance landscape. The company achieved net sales of Rs 7.77 crore, which represents a notable growth compared to the average net sales of Rs 3.21 crore over the previous four quarters. This figure marks the highest quarterly sales in the last five quarters, indicating a positive trend in sales activity.
However, the financial outlook is overshadowed by significant losses. The Profit Before Tax less Other Income (PBT) fell to Rs -7.52 crore, which is a substantial decline from the previous four-quarter average of Rs 0.06 crore. Similarly, Profit After Tax (PAT) decreased to Rs -7.35 crore, reflecting a considerable drop compared to the average PAT of Rs 0.04 crore in prior quarters. Operating Profit also reached a low of Rs -6.27 crore, marking the lowest figure in five quarters. The Earnings per Share (EPS) stood at Rs -3.50, indicating challenges in profitability and earnings for shareholders. Additionally, the company saw an adjustment in its evaluation, reflecting the overall financial performance. The quarterly results indicate that while net sales showed growth, the losses in profitability metrics present a challenging operational environment for Sampre Nutritions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sampre Nutritions Ltd is Rated Strong Sell
Mar 31 2026 10:10 AM IST
share
Share Via
Sampre Nutritions Ltd is Rated Sell
Mar 12 2026 10:10 AM IST
share
Share Via
Sampre Nutritions Ltd is Rated Sell
Feb 28 2026 10:10 AM IST
share
Share Via
Sampre Nutritions Ltd is Rated Sell
Feb 17 2026 10:10 AM IST
share
Share Via